Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03625505
Title A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Gilteritinib + Venetoclax

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
David Geffen School of Medicin /ID# 200166 Los Angeles California 90095 United States Details
UC San Francisco Medical Center-Parnassus /ID# 200205 San Francisco California 94143-2202 United States Details
Sylvester Comprehensive Cancer /ID# 200268 Miami Florida 33136-1002 United States Details
Northwestern Memorial Hospital /ID# 200230 Chicago Illinois 60611-2927 United States Details
Norton Cancer Institute /ID# 200623 Louisville Kentucky 40202-3700 United States Details
Johns Hopkins University /ID# 200349 Baltimore Maryland 21287 United States Details
Mayo Clinic - Rochester /ID# 200346 Rochester Minnesota 55905-0001 United States Details
Hackensack Univ Med Ctr /ID# 200229 Hackensack New Jersey 07601 United States Details
Weill Cornell Medical College /ID# 200109 New York New York 10065 United States Details
Hosp of the Univ of Penn /ID# 200348 Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center at Texas Medical Center /ID# 206686 Houston Texas 77030-4000 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field